Eptazocine hydrobromide

氢溴酸依他佐辛

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEptazocine hydrobromide
Drug Alias NameSedapain
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor antagonistsKappa opioid receptor agonists
TargetsMu opioid receptorKappa opioid receptor
Therapy Area/IndicationsCancer PainPain, Postoperative
Global Approved IndicationsCancer PainPain, Postoperative
Approved Indications in ChinaCancer PainPain, Postoperative
Original Approved Country/TerritoryJapan
Original Approved Date1987/01/12
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNichi-Iko Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNichi-Iko Pharmaceutical Co LtdShenzhen Main Luck Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCancer PainPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN02AD
Related LinksWikipediaKEGG